Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Contact lens fit study aims for perfect match

NCT ID NCT06884202

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This completed study tested how well delefilcon A contact lenses with different diameters and base curves fit the eyes of 257 people with nearsightedness. Researchers checked lens movement and centration right after insertion and again after 6 hours. The goal was to find which lens sizes provide the best fit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Delefilcon A contact lenses
What this could lead to
If successful, this could help eye doctors choose the best-fitting contact lens for people with nearsightedness, improving comfort and vision.
What could go wrong
This is a completed fitting study, not a treatment trial. It does not test whether the lenses improve vision or eye health long-term. Results may not apply to all lens wearers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

267 people

The number who actually took part.

Started

Apr 2025

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Successful wearer of spherical soft contact lenses in both eyes for a minimum of 5 days per week and a minimum of 6 hours per day during the past 3 months; * Able to wear contact lenses within a range of sphere powers from -2.00 and -4.00 diopters (D); * Best Corrected Visual Acuity (BCVA) (with manifest refraction) better than or equal to 0.10 logarithm Minimum Angle of Resolution (logMAR ) in each eye. Key Exclusion Criteria: * Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator; * History of refractive surgery or plan to have refractive surgery during the study, or irregular cornea in either eye; * Biomicroscopy findings at screening that are moderate (Grade 3) or higher and/or corneal vascularization that is mild (Grade 2) or higher; presence of corneal infiltrates. Other protocol-defined inclusion/exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Coldwater Vision Research

    Coldwater, Mississippi, 38618, United States

  • Dr. Schwartz Optometrist and Associates

    Sterling Heights, Michigan, 48312, United States

  • Elsa Pao, OD

    Oakland, California, 94607, United States

  • Eyecare Professionals, Inc

    Powell, Ohio, 43065, United States

  • Eyeconic Family Eyecare

    Dallas, Georgia, 30157, United States

  • Kindred Optics at Maitland Vision

    Maitland, Florida, 32751, United States

  • Kurata Eyecare Center

    Los Angeles, California, 90013, United States

  • NC Eye Associates, OD, PLLC

    Apex, North Carolina, 27502, United States

  • Pacific Rims Optometry

    San Francisco, California, 94127, United States

  • Pearson Research Center, PA

    Longwood, Florida, 32779, United States

  • ProCare Vision Centers, Inc.

    Granville, Ohio, 43023, United States

  • SUNY College of Optometry Clinical Vision Research Center

    New York, New York, 10036, United States

  • See Eye Care Optometry

    Charlotte, North Carolina, 28278, United States

  • Southern College of Optometry

    Memphis, Tennessee, 38104, United States

  • West Bay Eye Associates

    Warwick, Rhode Island, 02888, United States

  • Wyomissing Optometric Center

    Wyomissing, Pennsylvania, 19610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.